Low High-Density Lipoprotein and Risk of Myocardial Infarction.
Clin Med Insights Cardiol
; 9: 113-7, 2015.
Article
em En
| MEDLINE
| ID: mdl-26692765
AIM-HIGH; Apo; ApoA-I; ApoA-II; Biosynthesis; CETP; HDL; HDL subclass; HDL-C; HP2-THRIVE; LDL; LIPG; ODYSSEY; OSLER; PAF-AH; PCSK; PCSK9; PON1; TRIUMPH; acetylhydrolase; alirocumab; apolipoprotein; atheroprotective; cholesterol; convertase; dyslipidemia; elimination; endothelial lipase gene; evolocumab; heart attack; high density lipoprotein; hyperlipidemia; kexin; low HDL; monoclonal antibody; myocardial infarction; niacin; paraoxonase-1; platelet activating factor; praluent; proprotein; repatha; review; statin; storage; sublisin
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2015
Tipo de documento:
Article